Le rapport « Place des vaccins bivalents contre la Covid-19 Comirnaty Original/Omicron BA.1 et Comirnaty Original/Omicron BA.4-BA.5 », ci-joint, est adopté
Voir aussi
Recommandation vaccinale
20/09/2022
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
fA0zRvafcmDN9aC7